Clinical Trials Browser

Interventional × Prostatic Neoplasms × cirmtuzumab × Clear all

NCT05156905 2024-10-09

Study of Docetaxel Combined with Cirmtuzumab in Metastatic Castration Resistant Prostate Cancer

Phase 1 Terminated

Prostatic Neoplasms